Research ArticleEditor's Page
177Lu-PSMA617 and the VISION Trial: One of the Greatest Success Stories in the History of Nuclear Medicine
Johannes Czernin and Jeremie Calais
Journal of Nuclear Medicine August 2021, 62 (8) 1025-1026; DOI: https://doi.org/10.2967/jnumed.121.262710
Johannes Czernin
Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, Los Angeles, California
Jeremie Calais
Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, Los Angeles, California

Article Figures & Data
Figures
Johannes Czernin
In this issue
Journal of Nuclear Medicine
Vol. 62, Issue 8
August 1, 2021
177Lu-PSMA617 and the VISION Trial: One of the Greatest Success Stories in the History of Nuclear Medicine
Johannes Czernin, Jeremie Calais
Journal of Nuclear Medicine Aug 2021, 62 (8) 1025-1026; DOI: 10.2967/jnumed.121.262710
Jump to section
Related Articles
- No related articles found.